In this tumor board, the participants will be able to:

• Define molecular residual disease (MRD) in mCRC patients undergoing metastasectomy
• Discuss pattern of failure after resection of mCRC metastases
• Discuss the role of imagining, CEA, and cDNA in the detection of recurrence after CRC resection

Moderators: 
June S. Peng, MD, Assistant Professor of Surgery, Penn State Cancer Institute and
Jan Franko, MD, PhD, FACS, FSSO, Surgical Oncologist, MercyOne Des Moines Surgical Group 

Panelists:
Fadi Dahdaleh, MD, Surgical Oncologist, Edward-Elmhurst Healthcare
Kanika Nair, MD, Medical Oncologist, Cleveland Clinic
Colette R. Pameijer, MD, Professor of Surgery and Chief, Penn State Cancer Institute